Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Fukushima Medical University, School of Medicine

5 abstracts

Abstract
Pertuzumab retreatment in patients with HER2-positive locally advanced/metastatic breast cancer: Overall survival results of a phase III randomized trial (JBCRG-M05: PRECIOUS).
Org: Aichi Cancer Center Hospital, Osaka University Graduate School of Medicine, Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Toranomon Hospital, St. Marianna University Hospital,
Abstract
Trastuzumab and pertuzumab in combination with eribulin mesylate or a taxane as first-line chemotherapeutic treatment for HER2-positive, locally advanced or metastatic breast cancer: Results of a multicenter, randomized, non-inferiority phase 3 trial in Japan (JBCRG-M06/EMERALD).
Org: Kanagawa Cancer Center, Fukushima Medical University, School of Medicine, Cancer Institute Hospital of the Japanese Foundation for Cancer Research (JFCR), National Cancer Center Hospital East, Kashiwa, Japan, Department of Breast Surgery, Shizuoka General Hospital,
Abstract
Benefit of perioperative chemotherapy in the patients with loco-regional recurrence of HR-positive HER2-negative breast cancer: A multi-institutional retrospective cohort study.
Org: Breast Medical Oncology Department, Cancer Institute Hospital of the Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan, Cancer Institute Hospital of the Japanese Foundation for Cancer Research (JFCR), Fukushima Medical University, School of Medicine, Department of Breast Oncology, Cancer Hospital of Xinjiang Medical University, Urumuqi, China, Research Institute for Radiation Biology and Medicine,
Abstract
The exploratory case-control study on prediction of immune checkpoint inhibitor-induced thyroiditis by human leukocyte antigen types.
Org: Fukushima Medical University, School of Medicine, Kyoto University Graduate School of Medicine,
Abstract
ASSOCIATION BETWEEN TREATMENT GOAL ACHIEVEMENT AND GRIT PERSONALITY CHARACTERISTICS OF ATTENDING PHYSICIAN IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTER CROSS-SECTIONAL STUDY
Org: Kochi Medical School, Okayama University Graduate School of Medicine, Showa University School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, Yokohama City University Graduate School of Medicine, Yokohama-Shi Kanazawa-Ku, KANAGAWA-KEN, Japan,